UPS to spend $48M on pharmaceutical cold-chain facilities amid GLP-1 demand surge

UPS is beefing up its cold-chain logistics network with a $48 million investment in upgrading 27 temperature-controlled facilities worldwide, highlighting a surge in demand for pharmaceuticals requiring strict cold storage. This move underscores the growing importance of healthcare logistics in the supply chain, particularly for GLP-1 drugs used in weight loss and diabetes treatments. The expansion reflects both a strategic response to market trends and an effort to meet regulatory standards for pharmaceutical distribution.